Colin Farrell is elaborating on a big parenting decision he made. The “Penguin” star, 48, revealed in a new interview with Candis magazine that he and his ex, model Kim Bordenave, put their ...

Affected populations: The disorder is believed to affect somewhere between 1 in 12,000 and 1 in 24,000 people, although these figures may be underestimated. Many cases of Angelman syndrome can go ...

Irish actor Colin Farrell has movingly detailed the choice to place his 21-year-old son in long-term care. The Dublin native opened up on the journey that first saw his son James incorrectly diagnosed ...

ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...

EASY TO MAKE FOR PEOPLE LIVING WITH DEMENTIA. WELL, TODAY WAS THE ANNUAL CHICAGO MARATHON AND EVERY YEAR, TENS OF THOUSANDS OF RUNNERS TAKE TO THE STREETS OF CHICAGO FOR 26.2 MILES. BUT ONLY A DOZEN ...

Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — When a child is born, so is a whole host of hopes and dreams. “When you hold your child for the first time, ...

Ultragenyx Pharmaceutical (NASDAQ:RARE) announced Saturday that GTX-102, its candidate for the rare neuro-genetic disorder Angelman syndrome, improved patient outcomes across multiple domains in a ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 ...

Positive End of Phase 2 discussion with FDA, including alignment on Phase 3 design Bayley-4 expressive communication selected as Phase 3 study primary endpoint Initiation of ION582 Phase 3 study ...

Colin Farrell has made the hard decision to put his 21-year-old son James, who suffers from Angelman syndrome, in a long-term care facility. “It’s tricky – some parents will say, ‘I want to take care ...